Supraclavicular Block vs Retroclavicular Block: Incidence of Phrenic Nerve Paralysis

October 18, 2019 updated by: Kamen Vlassakov, Brigham and Women's Hospital

Ultrasound Guided Supraclavicular Brachial Plexus Block vs Retroclavicular Brachial Plexus Block: Comparison of Impact on Ipsilateral Diaphragmatic Function

The aim of this study is to evaluate differences between ultrasound guided supraclavicular versus retroclavicular brachial plexus blocks: two similar brachial plexus nerve block techniques that differ in their needle trajectory and injection site.

Study Overview

Detailed Description

To date, there has not been a study that has compared clinically the retroclavicular brachial plexus block to the supraclavicular brachial plexus block or other brachial plexus blocks. The aim of this study is to evaluate differences between ultrasound guided supraclavicular versus retroclavicular brachial plexus blocks, with primary focus on the incidence of diminished ipsilateral hemidiaphramatic excursion (ipsilateral phrenic nerve blockade). We will also evaluate differences between the two techniques in the success of producing surgical anesthesia, procedural time to perform the block (including imaging time and needling time), block onset time, ease of quality ultrasound needle visualization, and incidence of paresthesias, vascular puncture and pneumothorax. Lastly, we will observe and compare the distribution of motor and sensory blockade of the two techniques

Study Type

Interventional

Enrollment (Actual)

44

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Massachusetts
      • Boston, Massachusetts, United States, 02115
        • Kamen Vlassakov

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (ADULT, OLDER_ADULT)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  1. patients scheduled for lower arm surgery
  2. patients aged 18 years or older
  3. patients ASA class I-III

Exclusion Criteria:

  1. Patients unable to cooperate or consent to the study
  2. pre-existing neuropathy
  3. significant pulmonary disease
  4. contralateral phrenic nerve or diaphragmatic dysfunction
  5. allergy to local anesthetics
  6. infection at needle insertion site
  7. history of coagulopathy
  8. BMI > 40 kg/m2

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: TREATMENT
  • Allocation: RANDOMIZED
  • Interventional Model: PARALLEL
  • Masking: TRIPLE

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
ACTIVE_COMPARATOR: Supraclavicular BPNB
Patients in this group will be randomized to receive an Ultrasound Guided Supraclavicular Brachial Plexus Nerve Block and outcomes will be measured over the perioperative and 1day time period.
An ultrasound-guided supraclavicular or retroclavicular nerve block with 30 ml of 0.5% ropivicaine will be performed on patients scheduled for lower arm surgery; 25 ml to be delivered to the brachial plexus and 5 ml to the intercostal nerve
ACTIVE_COMPARATOR: Retroclavicular BNPB
Patients in this group will be randomized to receive an Ultrasound Guided Retroclavicular Brachial Plexus Nerve Block and outcomes will be measured over the perioperative and 1day time period.
An ultrasound-guided supraclavicular or retroclavicular nerve block with 30 ml of 0.5% ropivicaine will be performed on patients scheduled for lower arm surgery; 25 ml to be delivered to the brachial plexus and 5 ml to the intercostal nerve

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Incidence of IIpsilateral Diaphragmatic Paresis
Time Frame: 30 minutes post block, then postoperatively
As evidence by ipsilater diagphragmatic excursion measured by Mmode ultrasound
30 minutes post block, then postoperatively

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Anesthetic and analgesic efficacy
Time Frame: 30 minutes post block, then postoperatively
Block success will be defined as onset of acceptable sensory and motor blockade
30 minutes post block, then postoperatively
Procedural times (imaging time and needling time), onset time, ease of placement, and block duration
Time Frame: at the time of block
Ultrasonographic block imaging times (time between ultrasound probe placement on the patient and satisfactory image of target anatomy acquisition. needling time (time between needle insertion into the skin and the end of local anesthetic injection through the block needle), onset and duration of sensory block, and proceduralist's rating of ease of block performance will be measured.
at the time of block
Complication rates
Time Frame: 1 day
Rates of vascular puncture, pneumothorax and paresthesias will be recorded
1 day
Nerve block distribution
Time Frame: 30 minutes post block
measured through sensation (cold and pin prick) over dermatomes of the brachial plexus
30 minutes post block

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Kamen Vlassakov, MD, kvlassakov@partners.org

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (ACTUAL)

December 7, 2017

Primary Completion (ACTUAL)

June 20, 2019

Study Completion (ACTUAL)

June 21, 2019

Study Registration Dates

First Submitted

December 4, 2015

First Submitted That Met QC Criteria

December 15, 2015

First Posted (ESTIMATE)

December 16, 2015

Study Record Updates

Last Update Posted (ACTUAL)

October 22, 2019

Last Update Submitted That Met QC Criteria

October 18, 2019

Last Verified

October 1, 2019

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Phrenic Nerve Paralysis

Clinical Trials on Supraclavicular vs Retroclavicular Nerve Block

3
Subscribe